Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 173

1.

Vitamin D-binding protein (DBP) gene polymorphism is associated with Graves' disease and the vitamin D status in a Polish population study.

Kurylowicz A, Ramos-Lopez E, Bednarczuk T, Badenhoop K.

Exp Clin Endocrinol Diabetes. 2006 Jun;114(6):329-35.

PMID:
16868893
2.

A polymorphism within the vitamin D-binding protein gene is associated with Graves' disease but not with Hashimoto's thyroiditis.

Pani MA, Regulla K, Segni M, Hofmann S, Hüfner M, Pasquino AM, Usadel KH, Badenhoop K.

J Clin Endocrinol Metab. 2002 Jun;87(6):2564-7.

PMID:
12050214
3.

Lymphoid tyrosine phosphatase (PTPN22/LYP) variant and Graves' disease in a Polish population: association and gene dose-dependent correlation with age of onset.

Skórka A, Bednarczuk T, Bar-Andziak E, Nauman J, Ploski R.

Clin Endocrinol (Oxf). 2005 Jun;62(6):679-82.

PMID:
15943829
4.

The HLA-DQB alleles and amino acid variants of the vitamin D-binding protein in diabetic patients in Alsace.

Ongagna JC, Kaltenbacher MC, Sapin R, Pinget M, Belcourt A.

Clin Biochem. 2001 Feb;34(1):59-63.

PMID:
11239517
5.

Association of a common vitamin D-binding protein polymorphism with inflammatory bowel disease.

Eloranta JJ, Wenger C, Mwinyi J, Hiller C, Gubler C, Vavricka SR, Fried M, Kullak-Ublick GA; Swiss IBD Cohort Study Group.

Pharmacogenet Genomics. 2011 Sep;21(9):559-64. doi: 10.1097/FPC.0b013e328348f70c.

PMID:
21832969
6.

Vitamin D binding protein gene and genetic susceptibility to type 2 diabetes mellitus in a Polish population.

Malecki MT, Klupa T, Wanic K, Cyganek K, Frey J, Sieradzki J.

Diabetes Res Clin Pract. 2002 Aug;57(2):99-104.

PMID:
12062854
7.

Association of vitamin D and vitamin D binding protein (DBP) gene polymorphism with susceptibility of type 2 diabetes mellitus in Bangladesh.

Rahman MM, Hosen MB, Faruk MO, Hasan MM, Kabir Y, Howlader MZH.

Gene. 2017 Dec 15;636:42-47. doi: 10.1016/j.gene.2017.09.008. Epub 2017 Sep 6.

PMID:
28888576
8.

The functional polymorphisms of VDR, GC and CYP2R1 are involved in the pathogenesis of autoimmune thyroid diseases.

Inoue N, Watanabe M, Ishido N, Katsumata Y, Kagawa T, Hidaka Y, Iwatani Y.

Clin Exp Immunol. 2014 Nov;178(2):262-9. doi: 10.1111/cei.12420.

9.

Association of CD40 gene polymorphism (C-1T) with susceptibility and phenotype of Graves' disease.

Kurylowicz A, Kula D, Ploski R, Skorka A, Jurecka-Lubieniecka B, Zebracka J, Steinhof-Radwanska K, Hasse-Lazar K, Hiromatsu Y, Jarzab B, Bednarczuk T.

Thyroid. 2005 Oct;15(10):1119-24.

PMID:
16279844
10.

rs3827440, a nonsynonymous single nucleotide polymorphism within GPR174 gene in X chromosome, is associated with Graves' disease in Polish Caucasian population.

Szymański K, Miśkiewicz P, Pirko K, Jurecka-Lubieniecka B, Kula D, Hasse-Lazar K, Krajewski P, Bednarczuk T, Płoski R.

Tissue Antigens. 2014 Jan;83(1):41-4. doi: 10.1111/tan.12259. Epub 2013 Nov 30.

PMID:
24289805
11.

Association of NFKB1 -94ins/del ATTG promoter polymorphism with susceptibility to and phenotype of Graves' disease.

Kurylowicz A, Hiromatsu Y, Jurecka-Lubieniecka B, Kula D, Kowalska M, Ichimura M, Koga H, Kaku H, Bar-Andziak E, Nauman J, Jarzab B, Ploski R, Bednarczuk T.

Genes Immun. 2007 Oct;8(7):532-8. Epub 2007 Aug 9.

PMID:
17690684
12.

Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Graves' disease in a Japanese population.

Ichimura M, Kaku H, Fukutani T, Koga H, Mukai T, Miyake I, Yamada K, Koda Y, Hiromatsu Y.

Thyroid. 2008 Jun;18(6):625-30. doi: 10.1089/thy.2007.0353.

PMID:
18578611
13.

Vitamin D-binding protein gene polymorphism association with IA-2 autoantibodies in type 1 diabetes.

Ongagna JC, Pinget M, Belcourt A.

Clin Biochem. 2005 May;38(5):415-9.

PMID:
15820770
14.

Influence of the TSH receptor gene on susceptibility to Graves' disease and Graves' ophthalmopathy.

Yin X, Latif R, Bahn R, Tomer Y, Davies TF.

Thyroid. 2008 Nov;18(11):1201-6. doi: 10.1089/thy.2008.0098.

15.

Vitamin D receptor gene polymorphism is associated with Graves' disease in the Japanese population.

Ban Y, Taniyama M, Ban Y.

J Clin Endocrinol Metab. 2000 Dec;85(12):4639-43.

PMID:
11134121
16.

Association analysis of vitamin D receptor gene polymorphisms with bone mineral density in young women with Graves' disease.

Horst-Sikorska W, Ignaszak-Szczepaniak M, Marcinkowska M, Kaczmarek M, Stajgis M, Slomski R.

Acta Biochim Pol. 2008;55(2):371-80. Epub 2008 May 26.

17.

beta-2-adrenergic receptor gene polymorphism confers susceptibility to Graves disease.

Jazdzewski K, Bednarczuk T, Stepnowska M, Liyanarachchi S, Suchecka-Rachon K, Limon J, Narkiewicz K.

Int J Mol Med. 2007 Jan;19(1):181-6.

18.

Interleukin-13 gene polymorphisms in patients with Graves' disease.

Bednarczuk T, Placha G, Jazdzewski K, Kurylowicz A, Kloza M, Makowska U, Hiromatsu Y, Nauman J.

Clin Endocrinol (Oxf). 2003 Oct;59(4):519-25. Erratum in: Clin Endocrinol (Oxf). 2003 Nov;59(5):658.

PMID:
14510917
19.

Association between the TAP2 gene codon 665 polymorphism and Graves' disease.

Chen RH, Wang TY, Chen WC, Tsai CH, Tsai FJ.

J Clin Lab Anal. 2006;20(3):93-7.

PMID:
16721835
20.

Supplemental Content

Support Center